Ultragenyx Pharmaceutical | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Insmed USD -234282000 14.77M 2024-12
Ionis Pharmaceuticals USD -147000000 40M 2025-03
Kyowa Hakko Kirin JPY 11.88B 13.17B 2024-12
MacroGenics USD -14477000 70.79M 2024-12
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Ultragenyx Pharmaceutical Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.